Farnesyl transferase inhibition in hematologic malignancies.
Karp
Judith E
JE
Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Harry and Jeanette Weinberg Building, Suite 1100, 401 North Broadway, Baltimore, MD 21231, USA. jkarp2@jhmi.edu
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D051231:Farnesyltranstransferase / Q000037:antagonists & inhibitors*; D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D015363:Quinolones / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D015363:Quinolones; D051231:Farnesyltranstransferase; C402769:tipifarnib